A patient has multiple gastric ulcers. Shortly after consuming a large meal he experiences significant GI distress- He takes an OTC heart-burn remedy. Within few minutes he develops severe pain and upper GI blood loss and is transported to the hospital. Endoscopy confirms multiple bleeds. Which of the following drugs or products did the patient most likely take?
Rationale:
Sodium bicarbonate. This antacid rapidly neutralizes stomach acid, which can lead to increased gastric acid production and rebound acidity, exacerbating ulcer symptoms and causing potential bleeding as experienced by the patient.
A: An aluminum salt. While aluminum salts can alleviate heartburn, they do not lead to rapid gastric acid rebound, making them less likely to cause acute complications in this scenario.
C: Magnesium hydroxide. Though effective for heartburn relief, magnesium hydroxide typically does not prompt significant acid rebound or worsen gastric ulcers, thus being an unlikely cause of the patient’s severe symptoms.
D: Ranitidine. As an H2 blocker, ranitidine reduces acid production but does not act quickly enough to cause immediate distress or bleeding after a large meal, rendering it an improbable choice.
Drugs useful in eradication of H. pylori include the following EXCEPT:
Rationale:
C: Rifampicin is not typically associated with the treatment of H. pylori infections, as it is more commonly used for tuberculosis and certain other bacterial infections. The standard eradication therapy focuses on antibiotics specifically effective against H. pylori.
A: Amoxicillin effectively targets H. pylori by disrupting its cell wall synthesis, making it a key component of combination therapy for eradication.
B: Clarithromycin inhibits bacterial protein synthesis and is frequently utilized in H. pylori treatment regimens, enhancing the effectiveness of eradication therapies.
D: Tetracycline also serves as an effective antibiotic against H. pylori, functioning by blocking protein synthesis, which is essential for the bacteria's growth and survival.
The most potent drug for prevention of motion sickness is
Rationale:
Scopolamine is the most potent drug for prevention of motion sickness. Its efficacy stems from its ability to block acetylcholine receptors in the vestibular system, effectively preventing nausea and vomiting associated with motion.
A: Dimenhydrinate The effectiveness of dimenhydrinate is limited compared to scopolamine, as it primarily addresses symptoms rather than preventing them, making it less potent for motion sickness prevention.
B: Tripelenamine This drug acts primarily as an antihistamine, which does not specifically target the mechanisms responsible for motion-induced nausea, leading to reduced effectiveness in prevention compared to scopolamine.
D: Hydroxygene Lacking established efficacy for motion sickness prevention, hydroxygene does not possess the same mechanism of action or potency as scopolamine, rendering it a less effective choice in this context.
Metronidazole is least likely to be effective in the treatment of
Rationale:
Metronidazole is least likely to be effective in the treatment of Pneumocystosis.
Pneumocystosis is primarily caused by Pneumocystis jirovecii, a fungus that does not respond to metronidazole, which is effective against anaerobic bacteria and certain protozoa, making it unsuitable for this fungal infection.
A: Amebiasis Metronidazole is a first-line treatment for amebiasis, effectively targeting Entamoeba histolytica, the causative protozoan.
B: Giardiasis This condition is caused by Giardia lamblia, and metronidazole is commonly prescribed as it effectively eliminates this protozoan infection.
D: Pseudomembranous colitis Metronidazole is often employed in treating this condition, which is caused by Clostridium difficile, making it a suitable choice for therapy.
The following drugs are associated with cholestatic jaundice/hepatitis:
Rationale:
D: Chlorpromazine is associated with cholestatic jaundice/hepatitis due to its ability to cause liver dysfunction through metabolic pathways, leading to bile salt accumulation and subsequent jaundice in susceptible individuals.
A: Ondansetron does not typically induce cholestatic jaundice/hepatitis, as its mechanism focuses on serotonin receptor antagonism without significant hepatotoxic effects on liver function.
B: Methotrexate primarily induces hepatotoxicity through different mechanisms, often involving direct liver damage and fibrosis, rather than specifically causing cholestatic jaundice or hepatitis.
C: Synthetic oestrogens are linked to liver issues, but their primary association is with hepatic steatosis and not specifically with cholestatic jaundice or hepatitis in the same manner as chlorpromazine.
On your way to an examination, you experience the vulnerable feeling that an attack of diarrhea is imminent. Which one of the following anti-diarrheal drugs could you buy without a prescription even though it is related chemically to the strong opioid-analgesic meperidine?
Rationale:
C: Loperamide is the anti-diarrheal drug that can be purchased over-the-counter and shares a chemical relationship with meperidine, providing effective relief from diarrhea by slowing gut movement without prescription requirements.
A: Aluminum hydroxide primarily acts as an antacid and does not address diarrhea directly, making it unsuitable for treating the imminent symptoms described in the scenario.
B: Sulfasalazine is primarily used to treat inflammatory bowel diseases and is not suitable for general diarrhea relief, thus failing to meet the immediate need presented in this situation.
D: Magnesium hydroxide serves as an antacid and laxative, which could exacerbate diarrhea symptoms rather than alleviate them, rendering it ineffective for the described urgency of the situation.
A 45-year-old patient who is taking a proton pump inhibitor, metronidazole, and clarithromycin. Which of the following is the most likely purpose for administering this drug combination?
Rationale:
C: Refractory or recurrent, and severe, gastric or duodenal ulcers secondary to H. pylori. This combination of a proton pump inhibitor with metronidazole and clarithromycin is typically prescribed to eradicate Helicobacter pylori, which is associated with chronic ulcers, particularly when previous treatments have failed or when the ulcers are severe and recurrent.
A: Antibiotic-associated pseudomembranous colitis. This condition arises from Clostridium difficile overgrowth, not from the treatment regimen targeting H. pylori, which is focused on ulcer management rather than colitis prevention.
B: Irritable bowel syndrome (IBS). IBS is a functional gastrointestinal disorder characterized by abdominal pain and altered bowel habits, unrelated to the antibiotic and proton pump inhibitor combination aimed at treating H. pylori infections.
D: Traveler's diarrhea, severe, Escherichia coli-induced, from drinking contaminated water. This drug regimen is not intended for bacterial infections caused by E. coli; it specifically targets H. pylori-related gastric ulcers and not travel-related gastrointestinal issues.
The following drugs are used to prevent motion sickness:
Rationale:
Hyoscine effectively prevents motion sickness by blocking the action of acetylcholine in the vestibular system, thereby reducing nausea and dizziness associated with travel. Its use is well-documented in clinical settings for this purpose.
B: Promethazine primarily serves as an antihistamine and is more effective for allergy symptoms than for preventing motion-related nausea. Its action does not specifically target vestibular disturbances.
C: Cinnarizine is primarily an antihistamine used for vertigo and is less commonly utilized for motion sickness prevention, making it a less reliable option in this context.
D: Metoclopramide is primarily an antiemetic that addresses nausea from various sources but does not specifically target motion sickness mechanisms, limiting its effectiveness in this scenario.
Loperamide is:
Rationale:
Loperamide is an anti-diarrheal. This medication specifically targets the gastrointestinal tract, reducing the frequency of bowel movements and alleviating symptoms associated with diarrhea, making it effective for managing this condition.
A: Analgesic anti-pyretic Loperamide does not relieve pain or reduce fever, which are the primary functions of analgesic anti-pyretic medications, thus it does not fit this classification.
B: Anti-tussive Loperamide does not suppress cough reflexes, which is the main function of anti-tussives; therefore, it does not serve this purpose in therapeutic applications.
D: Anti-emetic Loperamide does not prevent or treat nausea and vomiting, which is the primary action of anti-emetics, thus it does not align with this classification.
The success of oral rehydration therapy of diarrhoea depends upon the following process in the intestinal mucosa.
Rationale:
Glucose coupled Na⁺ absorption. This process enhances water absorption in the intestines by utilizing glucose to facilitate sodium transport, thereby effectively promoting rehydration during diarrheal episodes through oral rehydration therapy.
A: Sodium pump mediated Na⁺ absorption. This mechanism primarily relies on active transport, which does not directly enhance water uptake as effectively as glucose-coupled absorption in rehydration therapy.
C: Bicarbonate coupled Na⁺ absorption. While bicarbonate plays a role in fluid balance, its coupling with sodium does not primarily focus on enhancing water absorption as glucose does during diarrheal treatment.
D: Passive Na⁺ diffusion secondary to nutrient absorption. This process is a less efficient means of sodium uptake, lacking the active transport benefits that glucose-coupled absorption provides for effective rehydration.
A patient suffering from acute infectious diarrhea caused by Shigella can be managed in all of the following ways except
Rationale:
Management of acute infectious diarrhea caused by Shigella does not include the use of glucose solutions like soda or apple juice to settle the stomach and decrease stool frequency.
The use of glucose solutions can worsen the diarrhea by increasing osmotic load, leading to further fluid loss and electrolyte imbalance, which is particularly harmful in acute infections like Shigella.
A: no treatment because signs and symptoms usually resolve in 48 hours. While some mild cases resolve quickly, appropriate management is necessary to prevent dehydration and complications.
C: avoiding food for at least 6 hours, then slowly increasing fluid intake. This approach is often recommended to allow the gastrointestinal tract to rest and recover, making it a valid management strategy.
D: using antibiotics (e.g., Bactrim, doxycycline) for 7 days. Antibiotics are indicated in severe cases to reduce infection duration and severity, making this a viable treatment option for Shigella.
Cardiac arrhythmias have occurred when this drug was used by patients taking the gastrointestinal promotility agent cisapride
Rationale:
Cardiac arrhythmias have occurred when ketoconazole was used by patients taking the gastrointestinal promotility agent cisapride. Ketoconazole interacts with cisapride, increasing its levels and leading to potentially life-threatening heart rhythm disturbances, highlighting the importance of monitoring drug interactions in patients receiving these medications.
A: Amphotericin B This antifungal agent does not commonly interact with cisapride and is not associated with cardiac arrhythmias in the context of this drug combination.
B: Clotrimazole Clotrimazole primarily targets fungal infections and lacks documented interactions with cisapride that would result in significant cardiovascular effects, making it an unsuitable answer.
C: Griseofulvin As a dermatological antifungal, griseofulvin does not exhibit notable interactions with cisapride, and thus it does not contribute to the risk of cardiac arrhythmias in patients.
Which of the following statements about adsorbent drugs used for diarrhea is true?
Rationale:
D: Kaolin is now generally recognized as a safe and effective OTC antidiarrheal agent. This statement reflects current medical consensus, highlighting kaolin's efficacy and safety profile in treating diarrhea, making it a viable option for over-the-counter use.
A: Useful for treatment of severe diarrhea. While adsorbent drugs can help manage symptoms, they are not primarily recommended for severe cases, where hydration and other treatments are typically essential.
B: Very unsafe because not absorbed systemically. This statement misrepresents the safety profile of adsorbent drugs, as their non-systemic absorption is often a beneficial characteristic, reducing potential systemic side effects.
C: In general, small doses are needed to relieve diarrhea. This suggests a standard dosage that may not apply universally, as the effectiveness can vary significantly based on individual patient needs and specific conditions.
The concentration of sodium ions in WHO oral rehydration solution is
Rationale:
The concentration of sodium ions in WHO oral rehydration solution is 90 m moles/L. This concentration is vital for effective rehydration, as it helps restore electrolyte balance and promotes optimal absorption of fluids in cases of dehydration, particularly during diarrhea, ensuring rapid recovery and improved health outcomes.
A: 40 m moles/L This level of sodium ions is insufficient for effective rehydration, potentially failing to adequately restore electrolyte levels needed for proper physiological function.
B: 60 m moles/L While closer, this concentration still falls short of the recommended amount, limiting the solution's efficacy in treating dehydration effectively during gastrointestinal illnesses.
D: 110 m moles/L An excessive concentration that could lead to hypernatremia, posing health risks rather than providing balanced rehydration, hindering the therapeutic purpose of the solution.
For healing duodenal ulcer the usual duration of Hâ‚‚ blocker therapy is
Rationale:
The usual duration of Hâ‚‚ blocker therapy for healing duodenal ulcers is 8 weeks. This duration allows sufficient time for effective mucosal healing and symptom relief, as studies indicate that shorter treatments may not adequately address the ulcer's healing process, thus ensuring a more complete resolution of the condition.
A: 4 weeks This timeframe is often insufficient for complete healing of duodenal ulcers, which typically require longer treatment durations to achieve optimal results.
B: 6 weeks This duration may still fall short of the necessary time needed for adequate mucosal healing and may not fully address ulcer symptoms effectively.
D: 12 weeks Extending treatment to this length is unnecessary for most cases, as research suggests that 8 weeks is typically adequate for healing in duodenal ulcers.
Omeprazole exerts practically no other action except inhibition of gastric acid secretion because
Rationale:
Omeprazole exerts practically no other action except inhibition of gastric acid secretion because all the mentioned mechanisms contribute to its specific effect on gastric parietal cells. The drug activates in acidic pH, selectively binds to the H⁺ K⁺ ATPase, and its forms remain trapped within the canaliculi, ensuring targeted action without additional effects.
A: In transforms into the active cationic forms only in the acidic pH of the gastric juice. While pH activation is crucial, it does not encompass the entire reason for its selective action.
B: Its active forms have selective affinity for the H⁺ K⁺ ATPase located in the apical canaliculi of gastric parietal cells. Selective affinity is significant, yet it does not address the other mechanisms involved in its action.
C: Its cationic forms are unable to diffuse out from the gastric parietal cell canaliculi. While this retention is essential, it alone does not explain the complete lack of other actions of omeprazole.
A patient returning from dinner party meets with road accident and has to be urgently operated upon under general anaesthesia. Which drug can be injected intramuscularly to hasten his gastric emptying
Rationale:
Metoclopramide can be injected intramuscularly to hasten gastric emptying. This medication enhances gastrointestinal motility and accelerates gastric emptying, making it ideal for patients requiring urgent surgery after potential food intake.
A: Methypolysiloxane acts as an antifoaming agent, primarily alleviating discomfort from gas. It does not facilitate gastric emptying and is not suitable for urgent surgical preparations.
B: Promethazine serves as an antihistamine with sedative properties, often used for nausea and vomiting. It does not promote gastric motility or emptying, making it ineffective in this scenario.
D: Apomorphine functions as an emetic and induces vomiting, which is counterproductive in this situation. It does not support gastric emptying in a controlled manner required for surgery.
A patient with a 30-year history of type 1 diabetes comes to you with a complaint of bloating and sour belching after meals. On several occasions, vomiting has occurred after a meal. Evaluation reveals delayed emptying of the stomach, and you diagnose diabetic gastroparesis. Which of the following drugs would be most useful in this patient?
Rationale:
Metoclopramide would be most useful in this patient. This medication acts as a prokinetic agent, enhancing gastric motility and accelerating gastric emptying, which directly addresses the symptoms of diabetic gastroparesis experienced by the patient.
A: Famotidine reduces stomach acid secretion but does not improve gastric emptying or address symptoms related to diabetic gastroparesis, making it unsuitable for this condition.
C: Misoprostol is primarily used to prevent gastric ulcers and does not specifically target the motility issues present in diabetic gastroparesis, rendering it ineffective for this patient's symptoms.
D: Omeprazole is a proton pump inhibitor that decreases acid production and does not influence gastric emptying, failing to provide relief for the bloating and belching associated with gastroparesis.
Lansoprazole would be effective in the treatment of
Rationale:
Lansoprazole would be effective in the treatment of all of the above. This proton pump inhibitor reduces gastric acid secretion, making it beneficial for gastroesophageal reflux disease, peptic ulcer disease, and Zollinger-Ellison syndrome, effectively managing symptoms and promoting healing in each condition.
A: Gastroesophageal reflux disease This option addresses only one condition, whereas Lansoprazole is indicated for multiple disorders, limiting its scope compared to the broader category of all applicable diseases.
B: Peptic ulcer disease This choice focuses solely on ulcers, neglecting Lansoprazole’s efficacy in treating other acid-related disorders, thus failing to encompass the full range of its therapeutic uses.
C: Zollinger-Ellison syndrome This option highlights a specific syndrome but overlooks the broader applications of Lansoprazole, which are relevant to various gastrointestinal conditions beyond just this particular one.
Bisacodyl frequently can cause
Rationale:
Bisacodyl frequently can cause abdominal cramps. This side effect arises due to the stimulant action of Bisacodyl on the bowel, leading to increased peristalsis and discomfort in the abdominal area.
B: Constipation This option contradicts the primary action of Bisacodyl, which is to alleviate constipation rather than induce it, making it an unlikely effect of the medication.
C: Skin rashes Although skin rashes can occur with various medications, they are not commonly associated with Bisacodyl, which primarily affects the gastrointestinal system rather than causing dermatological reactions.
D: Dizziness Dizziness is not a typical side effect of Bisacodyl, as its mechanism primarily targets bowel movement stimulation, leaving systemic effects like dizziness outside its expected profile.
In peptic ulcer, antacids do have a primary role in
Rationale:
Antacids provide prompt relief of pain in peptic ulcer cases. They work by neutralizing stomach acid, which reduces irritation of the ulcerated tissue and alleviates the discomfort experienced by patients, leading to immediate symptom relief.
B: Ulcer healing Antacids do not promote the healing of ulcers; they primarily address symptoms by neutralizing acid, while healing depends on other medications and factors like lifestyle changes.
C: Control of bleeding Antacids are not designed to manage bleeding; their function is limited to symptom relief, and bleeding requires different therapeutic interventions for effective control.
D: Prevention of ulcer relapse Antacids do not prevent relapse; they temporarily relieve symptoms but do not address the underlying causes or mechanisms that lead to ulcer recurrence.
The following is a noncompetitive antagonist at the gastric parietal cell Hâ‚‚ receptor.
Rationale:
Noncompetitive antagonist at the gastric parietal cell Hâ‚‚ receptor is Loxatidine. This medication effectively inhibits histamine action at the receptor site, thereby reducing gastric acid secretion without directly competing with histamine for binding, making it distinct among Hâ‚‚ receptor antagonists.
A: Cimetidine This option primarily acts as a competitive antagonist and does not fit the noncompetitive classification required for this specific receptor activity.
C: Roxatidine Similar to Cimetidine, this drug predominantly functions as a competitive antagonist, failing to align with the noncompetitive nature specified in the question.
D: Rantidine This choice also serves as a competitive antagonist at the Hâ‚‚ receptor, lacking the necessary noncompetitive properties that define Loxatidine's function.
Lactulose:
Rationale:
Lactulose requires colonic bacteria for activity. This synthetic disaccharide is metabolized by gut flora, which produces short-chain fatty acids that facilitate osmotic action in the colon, promoting bowel movements.
A: Is a chemical stimulant to the colon. Lactulose does not function as a stimulant; instead, it relies on fermentation by colonic bacteria to exert its laxative effects.
B: Produces its effect 10-12 hours after an oral dose. The onset of lactulose can vary, typically taking 24 to 48 hours for effects to manifest, rather than the stated timeframe.
D: Should not be administered concurrently with bran. Combining lactulose with bran does not present a contraindication; both can be taken together to enhance bowel regularity and fiber intake.
The electrolyte composition of WHO oral rehydration solution is based upon that of
Rationale:
The electrolyte composition of WHO oral rehydration solution is based upon cholera stools in children.
This formulation is specifically designed to address the unique electrolyte losses experienced by children suffering from cholera, providing optimal rehydration and restoring electrolyte balance, which is crucial for recovery in pediatric cases.
A: Enterotoxigenic E. coli diarrhea stools do not reflect the specific electrolyte needs that are characteristic of cholera, thus failing to provide effective rehydration for cholera-related dehydration.
B: Cholera stools in adults may not accurately represent the electrolyte composition required for children, as pediatric cases often have different hydration needs and electrolyte loss patterns.
D: Rotavirus diarrhea stools differ in electrolyte composition from cholera stools, making them unsuitable for formulating a solution specifically designed to counteract the dehydration caused by cholera in children.
All of the following vasoconstrictors are deemed safe and effective for the temporary relief of itching and swelling except
Rationale:
Phenylpropanolamine 1%-10% is not considered safe and effective for temporary relief of itching and swelling. This option has been associated with significant side effects and lacks sufficient efficacy compared to other vasoconstrictors.
A: ephedrine 0.1%-1.25% demonstrates reliable vasoconstrictive properties, providing effective relief from itching and swelling without major adverse effects, making it a preferred choice in clinical practice.
B: epinephrine 0.005%-0.01% effectively constricts blood vessels and reduces inflammation, making it a commonly used vasoconstrictor for managing acute allergic reactions and associated symptoms.
D: phenylephrine 0.25% is recognized for its efficacy in alleviating itching and swelling through vasoconstriction, offering a safe option for temporary symptom relief in various applications.
A 52-year-old patient is taking well adjusted dosages of theophylline, warfarin, quinidine, and phenytoin for multiple medical problems. However, he starts taking a drug for some GI distress, but he presents with toxic effects from all his other medications, with elevation of their serum concentrations. Which was the drug the patient most likely took?
Rationale:
Cimetidine is the drug the patient most likely took.
Cimetidine is a known inhibitor of cytochrome P450 enzymes, which are responsible for metabolizing many drugs. Its use can lead to increased serum concentrations of theophylline, warfarin, quinidine, and phenytoin, resulting in toxic effects that the patient experienced.
B: Sucralfate does not significantly interact with the cytochrome P450 system, making it unlikely to elevate serum concentrations of the patient's other medications.
C: Famotidine does not inhibit cytochrome P450 enzymes to a significant degree, thus it would not cause the observed toxic effects on the patient's medication levels.
D: Nizatidine, similar to famotidine, lacks the potency to inhibit cytochrome P450 enzymes effectively, so it would not explain the increased serum concentrations of the other medications.
Which solution is used as an astringent?
Rationale:
Aluminum acetate topical solution USP is used as an astringent. This solution is effective in reducing irritation and inflammation, making it suitable for treating minor skin conditions and providing relief from itching.
A: Strong iodine solution USP exhibits antiseptic properties primarily, focusing on infection prevention rather than astringency in skin treatment applications. Its primary function does not align with astringent use.
C: Acetic acid NF serves as a disinfectant and has other therapeutic uses, but it does not specifically function as an astringent, lacking the properties needed for skin tightening.
D: Aromatic ammonia spirit USP is utilized for respiratory stimulation and faintness relief, with no relevance to astringent properties, as it does not constrict body tissues or reduce secretions.
Ranitidine is a new histamine receptor blocker. It is
Rationale:
Ranitidine is a more potent, competitive and selective antagonist of histamine at the gastric site. This designation highlights its ability to effectively inhibit histamine action while minimizing side effects associated with non-selective antagonists, making it a preferred choice in treating conditions like peptic ulcers.
A: Less potent, non competitive but selective antagonist of histamine at gastric site than cimetidine. This option misrepresents ranitidine’s potency and incorrectly describes its competitive nature in blocking histamine receptors.
B: More potent, non selective and most toxic histamine antagonist of histamine at gastric site. This choice falsely claims ranitidine’s non-selective nature and toxicity, whereas it is selectively designed for targeted action with reduced adverse effects.
D: None of the above. This option overlooks the factual characterization of ranitidine as a competitive and selective antagonist, failing to acknowledge that one of the provided choices accurately describes its properties.
All of following drugs can be used in treatment of peptic ulcer, EXCEPT:
Rationale:
Dexamethasone is not utilized in peptic ulcer treatment due to its potential to increase gastric acid secretion and inhibit protective mucosal factors, thereby exacerbating ulcer conditions rather than alleviating them.
A: Sucralfate forms a protective barrier on ulcer surfaces, promoting healing and is commonly prescribed for peptic ulcers, making it a viable treatment choice.
B: Pirenzepine is an anticholinergic agent that reduces gastric acid secretion, effectively aiding in the management of peptic ulcers, thus validating its use in treatment protocols.
C: Bismuth salts function by coating ulcers and providing a protective effect, while also possessing antibacterial properties against H. pylori, making them a relevant option in peptic ulcer therapy.
The following accelerate healing in gastric ulcers:
Rationale:
Stopping smoking promotes healing in gastric ulcers by reducing gastric acid secretion and enhancing blood flow to the stomach lining, which is crucial for recovery and tissue repair.
A: Diclofenac Nonsteroidal anti-inflammatory drugs like diclofenac can exacerbate gastric ulcers, leading to increased irritation and delayed healing rather than promoting recovery.
C: Corticosteroids These medications can impair the immune response and gastro-intestinal healing, potentially worsening ulcer conditions rather than facilitating their recovery.
D: Ranitidine While ranitidine reduces stomach acid, it does not directly aid in the healing process of gastric ulcers compared to lifestyle modifications like smoking cessation.
A patient has multiple gastric ulcers. Shortly after consuming a large meal he experiences significant GI distress- He takes an OTC heart-burn remedy. Within few minutes he develops severe pain and upper GI blood loss and is transported to the hospital. Endoscopy confirms multiple bleeds. Which of the following drugs or products did the patient most likely take?
Rationale:
Bicarbonate-based antacids, such as sodium bicarbonate, can lead to the rapid release of carbon dioxide in the stomach after a large meal, causing distension, increased gastric secretions, and potential ulcer bleeding. This aligns with the patient’s symptoms of severe pain and blood loss shortly after taking the remedy.
A: An aluminum salt This option does not correlate with the rapid onset of severe symptoms following a meal, as aluminum salts typically do not cause such acute gastrointestinal distress or bleeding.
C: Magnesium hydroxide This choice primarily acts as a laxative and does not usually lead to significant bleeding or pain shortly after consumption, making it unlikely for this patient’s scenario.
D: Ranitidine As an H2 antagonist, ranitidine reduces stomach acid production and would not cause the acute symptoms of pain and bleeding seen in this patient after a large meal.
Drugs useful in eradication of H. pylori include the following EXCEPT:
Rationale:
C: Rifampicin is not typically used in the eradication of H. pylori. Instead, it is primarily an antibiotic for treating tuberculosis and certain bacterial infections, lacking effectiveness against H. pylori specifically.
A: Amoxicillin effectively targets H. pylori by disrupting bacterial cell wall synthesis, making it a common choice in combination therapies for eradication.
B: Clarithromycin acts by inhibiting bacterial protein synthesis, proving beneficial in H. pylori treatment regimens, particularly in conjunction with other antibiotics for enhanced efficacy.
D: Tetracycline is utilized in H. pylori eradication therapies due to its ability to interfere with protein synthesis, contributing to the successful treatment when combined with other medications.
The most potent drug for prevention of motion sickness is
Rationale:
Scopolamine. This drug is widely recognized for its effectiveness in preventing motion sickness due to its ability to block acetylcholine receptors in the vestibular system, thereby reducing nausea and dizziness during travel.
A: Dimenhydrinate. While it alleviates nausea, it is not as potent as scopolamine in preventing motion sickness specifically, making it a less effective choice for this purpose.
B: Tripelenamine. This antihistamine has limited efficacy against motion sickness and is primarily used for allergies, lacking the targeted action that scopolamine provides for vestibular disturbances.
D: Hydroxygene. This substance does not have established benefits for motion sickness prevention and is not recognized in medical literature for this specific application, making it an unsuitable alternative.
Metronidazole is least likely to be effective in the treatment of
Rationale:
Metronidazole is least likely to be effective in the treatment of Pneumocystosis.
Pneumocystosis is primarily caused by Pneumocystis jirovecii, a fungus that does not respond to metronidazole, which is effective against anaerobic bacteria and certain protozoa. Thus, this drug lacks efficacy against fungal infections like Pneumocystosis, making it unsuitable for treatment.
A: Amebiasis Metronidazole is a first-line treatment for amebiasis, effectively targeting the Entamoeba histolytica parasite involved in this intestinal infection and promoting recovery.
B: Giardiasis Metronidazole is commonly prescribed for giardiasis, effectively addressing the Giardia lamblia protozoan responsible for this gastrointestinal disease and leading to resolution of symptoms.
D: Pseudomembranous colitis Metronidazole is utilized in treating pseudomembranous colitis caused by Clostridium difficile, demonstrating effectiveness in managing this condition and alleviating associated symptoms.
The following drugs are associated with cholestatic jaundice/hepatitis:
Rationale:
Chlorpromazine is associated with cholestatic jaundice/hepatitis. This antipsychotic medication can lead to liver dysfunction, presenting as jaundice, due to its effects on bile flow and hepatic metabolism, making it significant in assessing liver health in patients.
A: Ondansetron This antiemetic primarily targets nausea and vomiting without significant effects on the liver, thus not being a known contributor to cholestatic jaundice or hepatitis.
B: Methotrexate Although it can cause liver toxicity, it is more commonly associated with hepatotoxicity rather than specifically cholestatic jaundice or hepatitis, which distinguishes it from the correct answer.
C: Synthetic oestrogens These hormones can lead to liver effects but are not specifically linked to cholestatic jaundice/hepatitis, showing a different pattern of liver-related complications compared to chlorpromazine.
On your way to an examination, you experience the vulnerable feeling that an attack of diarrhea is imminent. Which one of the following anti-diarrheal drugs could you buy without a prescription even though it is related chemically to the strong opioid-analgesic meperidine?
Rationale:
C: Loperamide is an over-the-counter anti-diarrheal medication that works by slowing gut movement, making it suitable for immediate use to alleviate diarrhea symptoms. Its chemical relation to meperidine is significant, indicating its effectiveness while remaining safe for non-prescription use.
A: Aluminum hydroxide serves primarily as an antacid, not addressing diarrhea directly, and therefore would not provide the necessary relief in this situation.
B: Sulfasalazine is typically prescribed for inflammatory bowel diseases, thus not intended for immediate relief of acute diarrhea, making it unsuitable for this scenario.
D: Magnesium hydroxide acts as a laxative rather than an anti-diarrheal, which would exacerbate diarrhea symptoms rather than provide the needed relief during an examination.
A 45-year-old patient who is taking a proton pump inhibitor, metronidazole, and clarithromycin. Which of the following is the most likely purpose for administering this drug combination?
Rationale:
C: Refractory or recurrent, and severe, gastric or duodenal ulcers secondary to H. pylori. This drug combination targets Helicobacter pylori infections, which are known to cause chronic ulcers, thereby aiming to eradicate the bacteria and promote healing.
A: Antibiotic-associated pseudomembranous colitis. This condition typically arises from the use of antibiotics disrupting gut flora, not from the combination of drugs listed, which primarily targets H. pylori.
B: Irritable bowel syndrome (IBS). IBS is a functional gastrointestinal disorder unrelated to the eradication of H. pylori, and the medications listed do not address its underlying causes or symptoms.
D: Traveler's diarrhea, severe, Escherichia coli-induced, from drinking contaminated water. This combination is not aimed at treating E. coli infections; instead, it specifically focuses on managing H. pylori-related conditions.
The following drugs are used to prevent motion sickness:
Rationale:
Hyoscine effectively prevents motion sickness by blocking the action of acetylcholine in the inner ear and brain. This action reduces the signals that trigger nausea and vomiting associated with motion-related stimuli.
B: Promethazine Primarily utilized as an antihistamine, it alleviates allergy symptoms but is not primarily indicated for motion sickness prevention. Its effectiveness in this context is limited compared to specific alternatives.
C: Cinnarizine Although it has some efficacy in treating motion sickness, its main use is for vestibular disorders. It is not the first-line treatment for preventing motion sickness.
D: Metoclopramide This medication is primarily an antiemetic used for nausea and vomiting due to other causes, not specifically for motion sickness. Its mechanism does not target motion-induced symptoms effectively.
Loperamide is:
Rationale:
Loperamide is an anti-diarrheal. This medication works by slowing down gut movement, reducing the frequency of bowel movements, and improving stool consistency, effectively managing symptoms of diarrhea and providing relief for patients.
A: Analgesic anti-pyretic Loperamide does not alleviate pain or reduce fever, focusing solely on gastrointestinal issues, rather than addressing sensations of discomfort or temperature regulation.
B: Anti-tussive This classification pertains to cough suppression; Loperamide targets gastrointestinal conditions, lacking any functionality in managing respiratory symptoms or related cough reflex actions.
D: Anti-emetic Loperamide does not prevent or alleviate nausea and vomiting, as its primary action is confined to controlling diarrhea rather than addressing symptoms of gastrointestinal upset.
The success of oral rehydration therapy of diarrhoea depends upon the following process in the intestinal mucosa.
Rationale:
Oral rehydration therapy's success relies on glucose coupled Na⁺ absorption, which enhances sodium uptake through a symbiotic mechanism, ensuring effective fluid absorption and rapid rehydration in the intestines.
A: Sodium pump mediated Na⁺ absorption focuses solely on active transport without considering glucose's vital role in enhancing sodium absorption during rehydration therapy, thus limiting its effectiveness.
C: Bicarbonate coupled Na⁺ absorption does not directly facilitate the primary mechanism of oral rehydration, as it overlooks the synergistic relationship between glucose and sodium necessary for optimal results.
D: Passive Na⁺ diffusion secondary to nutrient absorption fails to address the active transport processes essential for effective rehydration, as it does not involve the critical coupling with glucose.
A patient suffering from acute infectious diarrhea caused by Shigella can be managed in all of the following ways except
Rationale:
A: no treatment because signs and symptoms usually resolve in 48 hours. This approach may overlook the potential severity of Shigella infections, which can require medical intervention despite symptom resolution in some cases.
B: use of glucose solutions (e.g., soda, apple juice) to settle the stomach and decrease the number of stools. These solutions can exacerbate diarrhea and may not provide the necessary hydration or nutritional support needed during an acute infection.
C: avoiding food for at least 6 hours, then slowly increasing fluid intake. This method helps the digestive system recover, allowing the body to focus on healing while preventing further irritation.
D: using antibiotics (e.g., Bactrim, doxycycline) for 7 days. Antibiotic treatment is crucial for severe cases of Shigella infection, as it helps combat the bacteria and reduce the duration of illness.
Cardiac arrhythmias have occurred when this drug was used by patients taking the gastrointestinal promotility agent cisapride
Rationale:
Cardiac arrhythmias have occurred when ketoconazole was used by patients taking the gastrointestinal promotility agent cisapride. Ketoconazole inhibits CYP3A4, leading to increased cisapride levels, which can trigger serious cardiac effects, making this combination particularly dangerous for patients.
A: Amphotericin B This antifungal agent does not interact with cisapride or influence its metabolism, leaving the risk of cardiac arrhythmias unperturbed in patients using these medications concurrently.
B: Clotrimazole While clotrimazole is an antifungal, it has a different mechanism of action and does not significantly affect the metabolism of cisapride, thus not posing arrhythmia risks.
C: Griseofulvin This antifungal is primarily used for dermatophyte infections and does not interact with cisapride, meaning it does not contribute to the risk of cardiac arrhythmias in patients taking both.
Which of the following statements about adsorbent drugs used for diarrhea is true?
Rationale:
D: Kaolin is now generally recognized as a safe and effective OTC antidiarrheal agent. This reflects its established use and acceptance in the medical community for treating diarrhea, providing reliable symptom relief.
A: Useful for treatment of severe diarrhea. While adsorbent drugs can help with mild cases, they are not typically recommended for severe diarrhea, which may require more intensive interventions.
B: Very unsafe because not absorbed systemically. The safety profile of adsorbent drugs is well established, and their lack of systemic absorption is actually an advantage, minimizing potential side effects.
C: In general, small doses are needed to relieve diarrhea. This statement overlooks the fact that the effectiveness of adsorbent drugs can vary, and some cases may require appropriate dosing beyond small amounts.
The concentration of sodium ions in WHO oral rehydration solution is
Rationale:
The concentration of sodium ions in WHO oral rehydration solution is 90 m moles/L. This concentration is scientifically established to effectively manage electrolyte balance and hydration during cases of dehydration caused by diarrhea or vomiting, ensuring optimal physiological function and recovery.
A: 40 m moles/L This level is too low to adequately replenish sodium ions, potentially leading to insufficient electrolyte restoration in dehydrated patients.
B: 60 m moles/L While closer, this concentration still falls short of the recommended amount needed for effective rehydration and maintaining electrolyte equilibrium.
D: 110 m moles/L This concentration exceeds the recommended levels, risking hypernatremia, which can cause serious health complications, including neurological issues and cardiovascular strain.
For healing duodenal ulcer the usual duration of Hâ‚‚ blocker therapy is
Rationale:
C: The usual duration of H₂ blocker therapy for healing duodenal ulcers is 8 weeks. This timeframe allows sufficient time for the medication to effectively reduce acid secretion and promote mucosal healing.
A: 4 weeks may not provide enough time for complete healing of a duodenal ulcer, as this duration is typically too short for effective treatment.
B: 6 weeks often falls short of the generally recommended duration, possibly resulting in inadequate healing and the potential for ulcer recurrence if treatment is stopped prematurely.
D: 12 weeks extends beyond the standard duration necessary for healing, which can lead to unnecessary prolonged medication use without significant additional benefit for the patient.
Omeprazole exerts practically no other action except inhibition of gastric acid secretion because
Rationale:
Omeprazole exerts practically no other action except inhibition of gastric acid secretion because all of the provided statements accurately describe its mechanisms of action in gastric parietal cells.
All three statements highlight distinct properties of omeprazole related to its function. They explain how it transforms, interacts selectively with ATPase, and remains confined within parietal cells, collectively reinforcing its specific role in acid secretion inhibition.
A: In transforms into the active cationic forms only in the acidic pH of the gastric juice. This property illustrates how omeprazole's activation is dependent on the acidic environment, limiting its effects elsewhere.
B: Its active forms have selective affinity for the H⁺ K⁺ ATPase located in the apical canaliculi of gastric parietal cells. This specificity indicates that omeprazole primarily targets a unique enzyme, establishing its focused action on gastric acid production.
C: Its cationic forms are unable to diffuse out from the gastric parietal cell canaliculi. This inability to exit confines its action to the gastric environment, preventing broader physiological effects beyond acid secretion.
A patient returning from dinner party meets with road accident and has to be urgently operated upon under general anaesthesia. Which drug can be injected intramuscularly to hasten his gastric emptying
Rationale:
Metoclopramide is the drug that can be injected intramuscularly to hasten gastric emptying. This medication enhances gastric motility and accelerates the passage of stomach contents, making it ideal for urgent surgical situations.
A: Methypolysiloxane primarily acts as an anti-foaming agent, reducing gas and bloating rather than facilitating gastric emptying, which is essential in this scenario.
B: Promethazine serves mainly as an antihistamine for allergies and nausea, lacking the specific properties required to effectively promote gastric emptying in urgent medical circumstances.
D: Apomorphine induces vomiting and is unsuitable for hastening gastric emptying, as it would instead delay the process by triggering emesis, complicating the patient's surgical preparation.
A patient with a 30-year history of type 1 diabetes comes to you with a complaint of bloating and sour belching after meals. On several occasions, vomiting has occurred after a meal. Evaluation reveals delayed emptying of the stomach, and you diagnose diabetic gastroparesis. Which of the following drugs would be most useful in this patient?
Rationale:
Metoclopramide is the most useful drug for this patient with diabetic gastroparesis. It increases gastric motility and accelerates gastric emptying, alleviating symptoms such as bloating and vomiting associated with delayed gastric emptying.
A: Famotidine reduces stomach acid secretion but does not enhance gastric motility, making it ineffective for treating the underlying issue of delayed gastric emptying in gastroparesis.
C: Misoprostol is primarily used for preventing gastric ulcers and does not address the motility issues present in diabetic gastroparesis, thus failing to relieve the patient's symptoms effectively.
D: Omeprazole is a proton pump inhibitor that reduces acid production, but it does not improve gastric emptying or treat the symptoms of gastroparesis in this patient.
Lansoprazole would be effective in the treatment of
Rationale:
Lansoprazole would be effective in the treatment of all of the above. This medication is a proton pump inhibitor, which reduces stomach acid production, making it suitable for treating gastroesophageal reflux disease, peptic ulcer disease, and Zollinger-Ellison syndrome, thus addressing a range of gastrointestinal conditions effectively.
A: Gastroesophageal reflux disease This option only highlights one condition, while lansoprazole's efficacy extends to multiple gastrointestinal issues, demonstrating its broader therapeutic application.
B: Peptic ulcer disease Focusing solely on peptic ulcers underrepresents lansoprazole's versatility, as it is effective for various acid-related disorders beyond just this single condition.
C: Zollinger-Ellison syndrome This choice limits its scope to a specific syndrome, ignoring lansoprazole's proven effectiveness in treating other conditions, thereby not encompassing its complete therapeutic potential.
Bisacodyl frequently can cause
Rationale:
Bisacodyl frequently can cause abdominal cramps. This stimulant laxative works by irritating the bowel lining, leading to increased peristalsis, which often results in cramping sensations as the intestines contract more forcefully.
B: Constipation Often used to relieve constipation, bisacodyl is designed to counteract this condition rather than cause it, making this choice contrary to the drug's intended purpose.
C: Skin rashes While skin rashes can occur with various medications, they are not a common or expected side effect of bisacodyl, which primarily affects the gastrointestinal system.
D: Dizziness This symptom does not directly correlate with bisacodyl's mechanism of action, which focuses on bowel stimulation rather than central nervous system effects that could induce dizziness.
In peptic ulcer, antacids do have a primary role in
Rationale:
Prompt relief of pain. Antacids neutralize stomach acid, providing immediate alleviation from the discomfort associated with peptic ulcers. This rapid action helps to reduce irritation and allows patients to experience momentary relief from their symptoms.
B: Ulcer healing Antacids do not promote the healing of ulcers; they merely alleviate symptoms rather than address the underlying causes of the ulcer itself.
C: Control of bleeding Antacids are not designed to manage bleeding in ulcers; other medical interventions are necessary to address hemorrhaging effectively.
D: Prevention of ulcer relapse Antacids do not prevent future occurrences of ulcers; long-term management requires additional medications and lifestyle changes to mitigate risk factors.
The following is a noncompetitive antagonist at the gastric parietal cell Hâ‚‚ receptor.
Rationale:
B: Loxatidine is a noncompetitive antagonist at the gastric parietal cell H₂ receptor, effectively inhibiting gastric acid secretion without competing with histamine, thus providing therapeutic benefits for conditions like peptic ulcers.
A: Cimetidine primarily acts as a competitive antagonist of the H₂ receptor, directly blocking histamine’s effect rather than functioning as a noncompetitive antagonist in gastric acid secretion.
C: Roxatidine, while an H₂ receptor antagonist, operates as a competitive antagonist rather than a noncompetitive one, limiting its effectiveness in the same manner as Loxatidine.
D: Ranitidine also functions as a competitive antagonist at the H₂ receptor, actively competing with histamine and not aligning with the noncompetitive mechanism described in the question.
Lactulose:
Rationale:
Lactulose requires colonic bacteria for activity. This is essential for its mechanism of action, as the gut bacteria ferment lactulose, leading to the production of osmotic agents that enhance bowel movements.
A: Is a chemical stimulant to the colon. Lactulose functions as an osmotic laxative rather than a chemical stimulant, which differentiates its action from direct irritants that stimulate bowel contractions.
B: Produces its effect 10-12 hours after an oral dose. The onset of lactulose's effects typically occurs within 24 to 48 hours, making this timing inaccurate for its expected action.
D: Should not be administered concurrently with bran. Lactulose can actually be combined with bran to enhance its laxative effects, contradicting the assertion that their concurrent use is inadvisable.
The electrolyte composition of WHO oral rehydration solution is based upon that of
Rationale:
The electrolyte composition of WHO oral rehydration solution is based upon cholera stools in children. This formulation is specifically designed to address the electrolyte losses and dehydration patterns observed in pediatric cholera cases, ensuring optimal rehydration and recovery for young patients suffering from this condition.
A: Enterotoxigenic E. coli diarrhea stools This option does not reflect the specific needs addressed by WHO's solution, which is tailored primarily to the unique electrolyte imbalances seen in cholera cases.
B: Cholera stools in adults This choice overlooks the distinct physiological differences between adults and children, as the formulation is primarily optimized for the pediatric population affected by cholera-related dehydration.
D: Rotavirus diarrhea stools The composition does not focus on rotavirus stools, which present a different clinical scenario and electrolyte loss pattern, necessitating a separate rehydration strategy.
All of the following vasoconstrictors are deemed safe and effective for the temporary relief of itching and swelling except
Rationale:
C: phenylpropanolamine 1%-10% is not considered safe and effective for temporary relief of itching and swelling due to its significant side effects and potential for serious health risks compared to other options.
A: ephedrine 0.1%-1.25% demonstrates safety and efficacy in reducing symptoms like itching and swelling, making it a viable choice in medical practice.
B: epinephrine 0.005%-0.01% effectively constricts blood vessels and reduces swelling, proving beneficial for acute allergic reactions and skin irritations.
D: phenylephrine 0.25% is known for its vasoconstrictive properties, providing effective relief from itching and swelling through its action on blood vessels.
A 52-year-old patient is taking well adjusted dosages of theophylline, warfarin, quinidine, and phenytoin for multiple medical problems. However, he starts taking a drug for some GI distress, but he presents with toxic effects from all his other medications, with elevation of their serum concentrations. Which was the drug the patient most likely took?
Rationale:
Cimetidine significantly inhibits cytochrome P450 enzymes, leading to increased serum concentrations of theophylline, warfarin, quinidine, and phenytoin, which explains the patient’s toxic effects after starting this medication.
B: Sucralfate does not interact with cytochrome P450 enzymes and primarily acts by forming a protective barrier in the gastrointestinal tract, thus it would not cause increased serum concentrations of these medications.
C: Famotidine has minimal interaction with cytochrome P450 enzymes and primarily reduces gastric acid secretion, making it unlikely to elevate serum levels of theophylline, warfarin, quinidine, or phenytoin.
D: Nizatidine, similar to famotidine, has limited effect on cytochrome P450 enzymes and serves mainly to decrease gastric acid production, which would not lead to toxicity in other medications.
Which solution is used as an astringent?
Rationale:
Aluminum acetate topical solution USP is used as an astringent. This solution effectively reduces skin irritation and inflammation by causing contraction of tissues, making it suitable for treating minor skin conditions and providing relief from itching.
A: Strong iodine solution USP primarily acts as an antiseptic, not an astringent, focusing on infection prevention rather than tissue contraction or irritation reduction.
C: Acetic acid NF serves as a mild antiseptic and is used in various applications, but does not possess the astringent properties necessary for treating skin irritations or inflammation.
D: Aromatic ammonia spirit USP is primarily utilized as a respiratory stimulant. Its role does not encompass astringent action, limiting its effectiveness for treating skin-related issues.
Ranitidine is a new histamine receptor blocker. It is
Rationale:
Ranitidine is a more potent, competitive and selective antagonist of histamine at the gastric site. This classification highlights its effectiveness in reducing gastric acid secretion compared to other histamine blockers.
A: Less potent, non competitive but selective antagonist of histamine at gastric site than cimetidine. This statement inaccurately describes ranitidine’s potency and competitive nature, which are more favorable than cimetidine’s profile.
B: More potent, non selective and most toxic histamine antagonist of histamine at gastric site. Ranitidine is not non-selective, nor does it exhibit high toxicity; it is designed for safer, targeted action.
D: None of the above. This option fails to recognize that choice C accurately describes ranitidine’s pharmacological characteristics, thus making it an invalid selection.
All of following drugs can be used in treatment of peptic ulcer, EXCEPT:
Rationale:
D. Prednisolone does not treat peptic ulcers as it is a corticosteroid that can inhibit healing and potentially exacerbate gastrointestinal issues, rather than promoting ulcer recovery or resolution.
A: Sucralfate forms a protective barrier over ulcers, allowing for healing while preventing further damage from stomach acid. Its specific mechanism makes it suitable for treating peptic ulcers.
B: Pirenzepine, an anticholinergic agent, reduces gastric acid secretion and alleviates ulcer symptoms, making it beneficial in the management of peptic ulcers through its action on gastric function.
C: Bismuth salts provide a protective coating on the stomach lining and have antimicrobial properties, helping to heal peptic ulcers and prevent further irritation from stomach acid.
The following accelerate healing in gastric ulcers:
Rationale:
Stopping smoking accelerates healing in gastric ulcers. Quitting smoking reduces gastric acid secretion and improves blood flow, which are essential for the healing process of ulcers, thus promoting faster recovery.
A: Diclofenac Nonsteroidal anti-inflammatory drugs like diclofenac can actually exacerbate gastric ulcers, increasing irritation and delaying the healing process rather than promoting recovery.
C: Corticosteroids Although corticosteroids are anti-inflammatory, they can impair the healing of gastric ulcers by increasing the risk of gastrointestinal bleeding and creating an adverse environment for recovery.
D: Ranitidine Ranitidine reduces stomach acid but does not directly influence the healing process of gastric ulcers, making it less effective than lifestyle changes like quitting smoking in enhancing recovery.